Myriad Genetics, Inc. (MYGN) Stock Split, History Data
Working capital analysis
In terms of working capital, Myriad Genetics, Inc. maintains a healthy position.
The total current assets of the company are valued at $274600000.
This represents a growth rate of -43.358% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $56900000, exhibiting a growth rate of -77.980% year-on-year.
The receivables, another significant portion of the current assets, are valued at $101600000.
The year-on-year growth rate for receivables is 11.281%.
The inventory, which forms a critical part of the assets, is valued at $20100000.
This represents a healthy year-on-year growth of 31.373%
On the liabilities side, the company's current liabilities total $137200000.
This reflects a growth rate of -32.844% over the previous year, indicating the company's financial obligations are well under control.
2022
2021
2020
2019
2018
2017
Cash and investments
56.90
258.40
93.20
93.20
110.90
102.40
Receavebles
101.60
91.30
138.60
138.60
102.10
111.30
Inventory
20.10
15.30
31.40
31.40
34.30
42.20
Other
20.40
38.40
41.70
46.40
9.40
12.90
Total Current Assets
274.60
484.80
348.60
348.60
326.40
317.10
Acc Payable
28.80
29.60
33.30
33.30
26.00
22.00
Short Term Debt
14.10
13.00
78.90
78.90
68.30
65.60
Other Current Liab
93.70
156.50
3.40
82.30
5.30
127.30
Current Liabilities
137.20
204.30
117.80
117.80
102.20
217.50
Capital Structure
When examining the capital structure of Myriad Genetics, Inc., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Myriad Genetics, Inc. has chosen to reinvest in the business rather than distribute as dividends.
